Neoplastic conversion in rat liver by the antihistamine methapyrilene demonstrated by a sequential syncarcinogenic effect with N-2-fluorenylacetamide
- 1 June 1984
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 74 (1) , 63-69
- https://doi.org/10.1016/0041-008x(84)90270-9
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- An enhancing effect of the antihistaminic drug methapyrilene on rat liver carcinogenesis by previously administered N-2-fluorenylacetamideToxicology and Applied Pharmacology, 1983
- Quantitative aspects of chemical carcinogenesis and tumor promotion in liver.Environmental Health Perspectives, 1983
- Must initiators come first? Tumorigenic and carcinogenic effects on skin of 3-methylcholanthrene and TPA in various sequencesBritish Journal of Cancer, 1982
- DNA damage induced by the antihistaminic drug methapyrilene hydrochlorideMutation Research Letters, 1982
- Proliferation of preneoplastic lesions after discontinuation of chronic DEN feeding in the development of hepatomas in ratBritish Journal of Cancer, 1981
- Aberrant methylation of liver DNA in rats during hepatotoxicityToxicology and Applied Pharmacology, 1981
- Characterization of DNA repair elicited by carcinogens and drugs in the hepatocyte primary culture/DNA repair testJournal of Toxicology and Environmental Health, 1981
- Liver Tumors Induced in Rats by Oral Administration of the Antihistaminic Methapyrilene HydrochlorideScience, 1980
- The sequential analysis of liver cancer inductionBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1980
- Nitrosation and mutagenicity of some amine drugsToxicology and Applied Pharmacology, 1980